Health
Early monoclonal antibody therapies beneficial for COVID-19, finds study – News-Medical.Net
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB)…
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression among patients with mild to moderate coronavirus disease 2019 (COVID-19). The findings reveal that the timing of initiating MAB therapy is a crucial factor in determining its efficacy against COVID-19. The study is currently available on the medRxiv* preprint server.
Background
Since the emergence…
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News20 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here